Clinical Trials

Nasopharyngeal Carcinoma, Camurati-Engelmann Syndrome

NCT06886347 2025-03-20

Metastatic Nasopharyngeal Carcinoma

Phase 1 Recruiting

47 enrolled

Nasopharyngeal Carcinoma

NCT04870840 2024-10-29

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

3 enrolled

Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT06611150 2024-09-27

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Phase 1 Recruiting

24 enrolled

Phase 1 Not yet recruiting

Nasopharyngeal Carcinoma

NCT06383507 2024-04-25

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

18 enrolled

GenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT04522050 2023-07-12

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

65 enrolled

Nasopharyngeal Carcinoma

NCT04636632 2022-11-07

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Carcinoma

NCT04073784 2022-04-26

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

41 enrolled

Nasopharyngeal Carcinoma

NCT05299203 2022-03-28

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

18 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Radiodermatitis

NCT00181220 2020-05-18

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Phase 1 Withdrawn

Nasopharyngeal Carcinoma

NCT01447056 2020-02-07

MALTED

Head & NeckLymphoidSarcoma

37 enrolled

Nasopharyngeal Carcinoma, Hodgkin Disease, Leiomyosarcoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders

NCT03925896 2019-09-12

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

27 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT03876574 2019-03-15

Hepatic Artery Infusion Pump for NPC Liver Metastases

16 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

49 enrolled

Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

NCT00431210 2017-04-18

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

28 enrolled

Nasopharyngeal Carcinoma

NCT00516087 2017-02-07

NATELLA

23 enrolled

Nasopharyngeal Carcinoma

NCT02761291 2016-05-16

Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma

18 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence, Epstein-Barr Virus Infections, Multiple Acyl Coenzyme A Dehydrogenase Deficiency

NCT02058017 2015-06-19

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Phase 1 Terminated

9 enrolled

Nasopharyngeal Carcinoma

NCT01462903 2014-11-24

A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

BreastGastrointestinalHead & Neck

20 enrolled

Nasopharyngeal Carcinoma, Breast Neoplasms, Carcinoma, Hepatocellular

NCT00515957 2012-04-16

DELLA

Phase 1 Withdrawn